Let's get Phase II funded!

Phase 1 of the Mistletoe Clinical trial that began in 2015 is complete and the results are now available! Believe Big and its many supporters spearheaded this making the first-ever mistletoe clinical trial in the United States a reality!

The conclusions from the trial deemed that Mistletoe improved a patient's quality of life and is safe. The recommended Mistletoe dosage was also determined via the trial. Overall, the trial results warranted doing a Phase II Trial, a significant accomplishment. All of this is very positive news and inspiring. Being green-lighted for Phase II just adds to the momentum of Mistletoe therapy use in the world of oncology medicine.

Our hearts at Believe Big are full of gratitude, love, and respect for your contributions and support. Let's celebrate the true blessing of these results! Let's get Phase II funded! Now that the maximum tolerated dose has been determined and its safety verified, it is possible to begin Phase II clinical trials, pending additional funding.

Mistletoe Clinical Trial - Phase II

By BELIEVE BIG INC

Mistletoe Clinical Trial - Phase II

Team Members